cefonicid has been researched along with clindamycin in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Johnson, JT; Maxwell, RA; Swanson, D; Wagner, RL; Yu, VL | 1 |
Naden, MG; Watt, B | 1 |
Bosso, JA; Marble, DA; Townsend, RJ | 1 |
Cenacchi, V; Farneti, G; Manfredi, R; Pasquini, E; Righi, M; Romei Bugliari, D | 1 |
2 trial(s) available for cefonicid and clindamycin
Article | Year |
---|---|
Cefonicid versus clindamycin prophylaxis for head and neck surgery in a randomized, double-blind trial, with pharmacokinetic implications.
Topics: Cefonicid; Clindamycin; Double-Blind Method; Head; Humans; Neck; Protein Binding; Surgical Wound Infection | 1991 |
Clindamycin/cefonicid in head and neck oncologic surgery: one-day prophylaxis is as effective as a three-day schedule.
Topics: Adult; Aged; Aged, 80 and over; Cefonicid; Clindamycin; Drug Administration Schedule; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Prospective Studies; Surgical Wound Infection; Treatment Outcome | 1995 |
3 other study(ies) available for cefonicid and clindamycin
Article | Year |
---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
The in-vitro activity of three long-acting cephalosporins against Bacteroides fragilis, Peptostreptococcus species and Clostridium perfringens.
Topics: Bacteroides fragilis; Cefamandole; Cefonicid; Cefotetan; Ceftriaxone; Clindamycin; Clostridium perfringens; Microbial Sensitivity Tests; Peptostreptococcus | 1988 |
Compatibility of clindamycin phosphate with aztreonam in polypropylene syringes and with cefoperazone sodium, cefonicid sodium, and cefuroxime sodium in partial-fill glass bottles.
Topics: Aztreonam; Cefamandole; Cefonicid; Cefoperazone; Cefuroxime; Cephalosporins; Clindamycin; Drug Combinations; Drug Incompatibility; Drug Packaging; Drug Stability; Syringes | 1988 |